Status:

COMPLETED

GLP-1 Receptor Targeting in Diabetic and Healthy Individuals

Lead Sponsor:

Radboud University Medical Center

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

21-60 years

Brief Summary

The purpose of the study is to determine whether there are differences in pancreatic uptake of the radiotracer between healthy individuals and patients with type 1 diabetes. If T1D patients have a mar...

Eligibility Criteria

Inclusion

  • type 1 Diabetes

Exclusion

  • breast feeding
  • pregnant

Key Trial Info

Start Date :

December 1 2012

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2014

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01825148

Start Date

December 1 2012

End Date

May 1 2014

Last Update

December 2 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Radboud University Nijmegen Medical Center

Nijmegen, Gelderland, Netherlands, 6500 HB

GLP-1 Receptor Targeting in Diabetic and Healthy Individuals | DecenTrialz